Ceftibuten molecular structure

Ceftibuten

Also known as: Cedax, Isocef, Keimax, Procadax

CAS Number: 97519-39-6

Third-Generation Oral Cephalosporin (Beta-Lactam)

Pharmacopeia Standards

USPEPJP

Mechanism of Action

Ceftibuten inhibits bacterial cell wall synthesis by acylating penicillin-binding proteins and blocking peptidoglycan transpeptidation. The unsubstituted 3-position and carboxypropenyl side chain give it exceptional stability against many plasmid- and chromosomally-mediated beta-lactamases while preserving oral bioavailability. Activity is strongest against Enterobacterales, Haemophilus influenzae and Moraxella catarrhalis, with limited Gram-positive coverage.

Technical Specifications

Generic / INN NameCeftibuten
CAS Registry Number97519-39-6
Molecular FormulaC15H14N4O6S2
Molecular Weight410.42 g/mol (anhydrous); 446.45 g/mol (dihydrate) g/mol
Typical PurityNLT 97.0% and NMT 102.0% on the anhydrous basis; trans isomer NMT 1.0%
Storage ConditionsStore at 2-8 C in tight, light-resistant containers under nitrogen; protect from moisture.
Shelf Life24 months under refrigerated storage in original sealed packaging
CategoryCephalosporins

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Oral capsules and powder for oral suspension; urinary tract infection and paediatric respiratory product lines; component of investigational oral combinations with beta-lactamase inhibitors.

Manufacturers (1+)

View all →
Contact (Premium)